Progenra, Inc.
- Biotech or pharma, therapeutic R&D
A novel PROTAC platform that stands apart from traditional PROTACs. Leadership in ubiquitin proteasome system drug discovery. Our novel PROTAC molecules target diseases including Alzheimer’s and Parkinson's diseases, coronavirus infection, and cancer.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}